From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage worsens
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...
Fox News11d
Lingering lung disorders 5 years post-COVID: Here's what to know
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
The Independent Singapore News12d
Duke-NUS discovery offers hope for pulmonary fibrosis treatment
SINGAPORE: A new study from Duke-NUS Medical School has identified a promising new avenue for tackling pulmonary fibrosis, a ...
Managed Healthcare Executive13d
Enhancing Patient Care in Progressive Pulmonary Fibrosis: Strategies for Addressing Unmet Needs and Optimizing Treatment Approaches
Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...
European Medical Journal13d
Pirfenidone for Pulmonary Fibrosis May Also Reduce Lung Cancer Risk
Pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer. Learn more.
Medscape3d
Inhaled Morphine for Palliation of Dyspnea in End-stage Cystic Fibrosis
Cystic fibrosis (CF) is an autosomal ... and bronchiectasis with resulting marked decline in pulmonary function. The only treatment for end-stage CF lung disease is lung transplantation.